How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials

American Journal of Medicine

Volumn 118, Issue 5, 2005, Pages 465-474

  Choudhry, Niteesh K ^a,b,d   Singh, Jeffrey M ^b   Barolet, Alan ^b,d   Tomlinson, George A ^b,c,d   Detsky, Allan S ^b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Coronary angiography; Meta analysis; Meta regression; Myocardial revascularization; Risk stratification; Unstable angina

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DEATH; EMBASE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MEDLINE; META ANALYSIS; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 18144431767     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.02.016     Document Type: Review

References (32)

1. M.E. Bertrand, M.L. Simoons, K.A. Fox Management of acute coronary syndromes in patients presenting without persistent ST segment elevation Eur Heart J 23 2002 1809 1840
2. T.J. Ryan, E.M. Antman, N.H. Brooks (Committee on Management of Acute Myocardial Infarction) 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation 100 1999 1016 1030
3. E. Braunwald, E.M. Antman, J.W. Beasley (Committee on the Management of Patients With Unstable Angina) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article a report of the American College of Cardiology/American Heart Association task force on practice guidelines J Am Coll Cardiol 40 2002 1366 1374
4. L. Wallentin, B. Lagerqvist, S. Husted FRISC II Investigators Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Fast Revascularisation during Instability in Coronary artery disease Lancet 356 2000 9 16
5. P.A. McCullough, W.W. O'Neill, M. Graham A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial J Am Coll Cardiol 32 1998 596 605
6. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
7. H.V. Anderson, C.P. Cannon, P.H. Stone One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction J Am Coll Cardiol 26 1995 1643 1650
8. W.E. Boden, R.A. O'Rourke, M.H. Crawford Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy N Engl J Med 338 1998 1785 1792
9. K.A. Fox, P.A. Poole-Wilson, R.A. Henderson Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Randomized Intervention Trial of unstable Angina Lancet 360 2002 743 751
10. R. Spacek, P. Widimsky, Z. Straka Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study Eur Heart J 23 2002 230 238
11. M. Clarke A. Oxman Cochrane Reviewers Handbook 4.1.4 2001 Cochrane Library, Issue 4, 2001. Oxford: Update Software, updated October 2001.
12. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
13. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 101 129
14. S.G. Thompson, J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573
15. W. DuMouchel, S.-L. Normand Computer-modeling and graphical strategies for meta-analysis D. Stangl D. Berry Meta-analysis in Medicine and Health Policy 2000 Marcel Dekker Inc New York, New York 127 177
16. D.J. Spiegelhalter, K.R. Abrams, J.P. Myles Bayesian Approaches to Clinical Trials and Health-Care Evaluation 2004 John Wiley & Sons Chichester, UK
17. C.B. Begg, M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. M. Egger, G. Davey Smith, M. Schneider, C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
19. D.A. Morrow, C.P. Cannon, N. Rifai Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction results from a randomized trial JAMA 286 2001 2405 2412
20. E.M. Antman, M.J. Tanasijevic, B. Thompson Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 335 1996 1342 1349
21. F.J. Neumann, A. Kastrati, G. Pogatsa-Murray Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes a randomized controlled trial JAMA 290 2003 1593 1599
22. P.A. McCullough, C.M. Gibson, P.M. Dibattiste Timing of angiography and revascularization in acute coronary syndromes an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol 17 2004 81 86
23. K.M. Akkerhuis, J.H. Alexander, B.E. Tardiff Minor myocardial damage and prognosis are spontaneous and percutaneous coronary intervention-related events different? Circulation 105 2002 554 556
24. D.P. de Arenaza, A. Bakhai, M. Flather Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes N Engl J Med 345 2001 1573 1575
25. A.J. Nordmann, P. Hengstler, T. Harr Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction a meta-analysis of randomized controlled trials Am J Med 116 2004 253 262
26. G. Karthikeyan, B. Bhargava Prevention of restenosis after coronary angioplasty Curr Opin Cardiol 19 2004 500 509
27. S.A. Harding, D.L. Walters, I.F. Palacios, S.N. Oesterle Adjunctive pharmacotherapy for coronary stenting Curr Opin Cardiol 16 2001 293 299
28. E. Boersma, R.A. Harrington, D.J. Moliterno Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198
29. P.G. Barnett, S. Chen, W.E. Boden Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction results of a randomized trial Circulation 105 2002 680 684
30. A.S. Desai, D.H. Solomon, P.H. Stone, J. Avorn Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris Am J Cardiol 92 2003 363 367
31. E.M. Mahoney, C.T. Jurkovitz, H. Chu Cost and cost-effectiveness of an early Invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA 288 2002 1851 1858
32. M. Janzon, L.A. Levin, E. Swahn Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast revascularisation during Instability in coronary artery disease Eur Heart J 23 2002 31 40